English
-
-
Dengue disease awareness
ISID39 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Dengue vector control: what works best
WSPID20 minutes -
Dengue in Latam - Understand Disease Control and the Value of Vaccination
Takeda8 minutes -
Dengue in APAC - Understand Disease Control and the Value of Vaccination
Takeda13 minutes -
Mosquito Longevity
ADVA22 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021